Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#191 / 200 Total
FCEL - Fuelcell Energy Inc - Stock Price Chart
TickerFCEL [NASD]
CompanyFuelcell Energy Inc
CountryUSA
IndustryElectrical Equipment & Parts
Market Cap122.39MEPS (ttm)-7.42
P/E-EPS this Y23.65%
Forward P/E-EPS next Y20.14%
PEG-EPS past 5Y32.19%
P/S0.95EPS next 5Y30.57%
P/B0.20EPS Q/Q18.09%
Dividend-Sales Q/Q66.84%
Insider Own0.35%Inst Own37.34%
Insider Trans0.00%Inst Trans4.10%
Short Float13.73%EarningsJun 06/b
Analyst Recom3.22Target Price7.38
Avg Volume1.59M52W Range3.58 - 21.60
FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Feasel MarkFormer OfficerJun 06 '25Proposed Sale6.5319,084124,651Jun 06 04:22 PM
Achanta ShankarEVP, Chf. Product &Tech Ofc.May 08 '25Option Exercise0.002,02002,020May 12 05:46 PM
Bingham Betsy BDirectorApr 15 '25Option Exercise0.003,36208,608Apr 23 05:29 PM
Dolger JoshuaGeneral Counsel & Corp SecDec 10 '24Option Exercise0.0040502,724Dec 12 05:41 PM
Dolger JoshuaGeneral Counsel & Corp SecDec 11 '24Option Exercise0.002,52505,158Dec 12 05:41 PM
OPRA - Opera Ltd ADR - Stock Price Chart
TickerOPRA [NASD]
CompanyOpera Ltd ADR
CountryNorway
IndustryInternet Content & Information
Market Cap1.65BEPS (ttm)0.73
P/E25.30EPS this Y8.89%
Forward P/E14.47EPS next Y30.00%
PEG1.40EPS past 5Y28.67%
P/S3.17EPS next 5Y18.03%
P/B1.78EPS Q/Q147.51%
Dividend4.34%Sales Q/Q42.29%
Insider Own-Inst Own15.23%
Insider Trans-Inst Trans11.58%
Short Float2.44%EarningsApr 28/b
Analyst Recom1.00Target Price26.08
Avg Volume525.71K52W Range10.11 - 22.50
Opera Ltd. engages in the provision of web browsers through its subsidiaries. Its products include Opera browser for Windows, iOS, and Linux computers, as well as the mobile apps Opera for Android, Opera Mini, Opera Touch, and Opera News. The company was founded in 1995 and is headquartered in Oslo, Norway.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Song LinOfficerApr 30 '25Proposed Sale16.8950,000844,500Apr 30 09:10 PM
Jacobsen FrodeOfficerApr 30 '25Proposed Sale16.8950,000844,500Apr 30 09:09 PM
Song LinOfficerMar 14 '25Proposed Sale17.1860,0001,030,800Mar 14 08:26 PM
Jacobsen FrodeOfficerMar 14 '25Proposed Sale17.1860,0001,030,800Mar 14 08:26 PM
Hong Kong Kunlun Tech Holding 10% OwnerDec 04 '24Proposed Sale20.072,442,70049,024,989Dec 04 06:25 PM
TNON - Tenon Medical Inc - Stock Price Chart
TickerTNON [NASD]
CompanyTenon Medical Inc
CountryUSA
IndustryMedical Devices
Market Cap7.74MEPS (ttm)-13.78
P/E-EPS this Y82.55%
Forward P/E-EPS next Y51.65%
PEG-EPS past 5Y-25.43%
P/S2.36EPS next 5Y61.35%
P/B1.38EPS Q/Q89.97%
Dividend-Sales Q/Q0.97%
Insider Own0.00%Inst Own2.01%
Insider Trans-Inst Trans40.56%
Short Float1.21%EarningsMay 13/a
Analyst Recom1.00Target Price2.75
Avg Volume251.94K52W Range0.85 - 15.79
Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company was founded by Richard Ferrari and Richard Ginn on June 19, 2012 and is headquartered in Los Gatos, CA.
EXFY - Expensify Inc - Stock Price Chart
TickerEXFY [NASD, RUT]
CompanyExpensify Inc
CountryUSA
IndustrySoftware - Application
Market Cap202.36MEPS (ttm)-0.11
P/E-EPS this Y-20.85%
Forward P/E7.73EPS next Y35.62%
PEG-EPS past 5Y-
P/S1.43EPS next 5Y2.81%
P/B1.50EPS Q/Q22.07%
Dividend-Sales Q/Q7.57%
Insider Own37.04%Inst Own34.40%
Insider Trans-2.17%Inst Trans5.68%
Short Float4.42%EarningsMay 08/a
Analyst Recom2.20Target Price4.00
Avg Volume628.73K52W Range1.45 - 4.13
Expensify, Inc. engages in the provision of a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. It operates under the United States and All Other Locations geographical segments. The company was founded by David Barrett and Witold Stankiewicz on May 1, 2008 and is headquartered in Portland, OR.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Barrett David MichaelChief Executive OfficerJul 01 '25Sale2.5630,00076,8001,528,480Jul 02 04:39 PM
Mills Jason FahrDirectorJun 17 '25Sale2.284,0689,275364,184Jun 18 08:50 PM
Vidal DanielDirectorJun 17 '25Sale2.283,3547,647295,817Jun 18 08:50 PM
Schaffer RyanChief Financial OfficerJun 17 '25Sale2.281,8834,293171,998Jun 18 08:49 PM
Barrett David MichaelChief Executive OfficerJun 17 '25Sale2.282,2475,123210,676Jun 18 08:49 PM
BHF - Brighthouse Financial Inc - Stock Price Chart
TickerBHF [NASD]
CompanyBrighthouse Financial Inc
CountryUSA
IndustryInsurance - Life
Market Cap2.80BEPS (ttm)8.36
P/E5.84EPS this Y-13.05%
Forward P/E2.25EPS next Y16.47%
PEG1.26EPS past 5Y-
P/S0.40EPS next 5Y4.62%
P/B0.54EPS Q/Q38.71%
Dividend-Sales Q/Q3129.73%
Insider Own1.09%Inst Own83.79%
Insider Trans-11.69%Inst Trans-2.54%
Short Float3.52%EarningsAug 07/a
Analyst Recom3.09Target Price59.50
Avg Volume857.87K52W Range40.00 - 64.12
Brighthouse Financial, Inc. operates as a holding company, which engages in the provision of life insurance and annuities through independent distribution channels and marketing arrangements with a diverse network of distribution partners. It operates through the following segments: Annuities, Life, Run-Off, and Corporate & Others. The Annuities segment product offerings include fixed, structured, income and variable annuities. The Life segment manufactures products to serve its target segments through a broad independent distribution network. The Run-Off segment includes structured settlements, pension risk transfer contracts, certain company-owned life insurance policies, funding agreements and universal life with secondary guarantees. The Corporate & Other segment refers to the general account investments and the separate account assets of the company. The company was founded in June 1863 and is headquartered in Charlotte, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHAPLIN C EDWARDDirectorJun 06 '25Option Exercise0.006,183049,898Jun 10 09:17 AM
Zlatkus Lizabeth HDirectorJun 06 '25Option Exercise0.003,85004,397Jun 10 09:15 AM
Offereins Diane EDirectorJun 06 '25Option Exercise0.003,850025,797Jun 10 09:10 AM
Inserra Michael J.DirectorJun 06 '25Option Exercise0.001,92507,698Jun 06 07:04 PM
Lambert MylesEVP,Chief Mktg.& Dist. OfficerJun 03 '25Sale58.668,400492,75327,377Jun 03 05:09 PM
ALEC - Alector Inc - Stock Price Chart
TickerALEC [NASD, RUT]
CompanyAlector Inc
CountryUSA
IndustryBiotechnology
Market Cap160.99MEPS (ttm)-1.26
P/E-EPS this Y-53.19%
Forward P/E-EPS next Y14.38%
PEG-EPS past 5Y6.31%
P/S1.82EPS next 5Y10.34%
P/B1.70EPS Q/Q-5.88%
Dividend-Sales Q/Q-76.88%
Insider Own24.84%Inst Own66.69%
Insider Trans-0.79%Inst Trans0.22%
Short Float8.22%EarningsMay 08/a
Analyst Recom2.12Target Price4.00
Avg Volume875.57K52W Range0.87 - 6.78
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Yaffe KristineDirectorJun 20 '25Sale1.441,0001,44095,409Jun 23 04:05 PM
GRASSO MARCChief Financial OfficerJun 02 '25Sale1.3416,48822,068296,072Jun 04 04:21 PM
Kenkare-Mitra SaraPresident and Head of R&DJun 02 '25Sale1.3423,89031,974512,252Jun 04 04:19 PM
Rosenthal ArnonChief Executive OfficerJun 02 '25Sale1.3452,08769,7132,414,657Jun 04 04:18 PM
Sara Kenkare-MitraOfficerJun 02 '25Proposed Sale1.3323,02030,617May 30 05:10 PM
NPCE - NeuroPace Inc - Stock Price Chart
TickerNPCE [NASD, RUT]
CompanyNeuroPace Inc
CountryUSA
IndustryMedical Devices
Market Cap312.24MEPS (ttm)-0.83
P/E-EPS this Y11.65%
Forward P/E-EPS next Y27.05%
PEG-EPS past 5Y5.83%
P/S3.70EPS next 5Y34.22%
P/B12.85EPS Q/Q33.66%
Dividend-Sales Q/Q24.28%
Insider Own30.79%Inst Own61.13%
Insider Trans-35.35%Inst Trans-2.37%
Short Float3.45%EarningsMay 13/a
Analyst Recom1.00Target Price17.12
Avg Volume353.58K52W Range5.45 - 18.98
NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ORBIMED ADVISORS LLC10% OwnerMay 14 '25Sale15.85168,1362,665,3333,238,199May 16 05:26 PM
Morrell MarthaCHIEF MEDICAL OFFICERFeb 21 '25Sale13.7278,3341,074,84481,993Feb 25 06:52 PM
KCK LTD.10% OwnerFeb 20 '25Sale9.405,270,84549,545,9430Feb 20 09:51 AM
Morrell MarthaCHIEF MEDICAL OFFICERJan 30 '25Sale15.002003,00086,762Jan 31 07:16 PM
Morrell MarthaCHIEF MEDICAL OFFICERJan 29 '25Sale15.001001,50086,962Jan 31 07:16 PM
OCC - Optical Cable Corp - Stock Price Chart
TickerOCC [NASD]
CompanyOptical Cable Corp
CountryUSA
IndustryCommunication Equipment
Market Cap39.82MEPS (ttm)-0.38
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y6.68%
P/S0.58EPS next 5Y-
P/B2.07EPS Q/Q56.91%
Dividend-Sales Q/Q8.92%
Insider Own30.54%Inst Own16.14%
Insider Trans0.00%Inst Trans11.38%
Short Float0.08%EarningsJun 05/b
Analyst Recom-Target Price-
Avg Volume223.48K52W Range2.02 - 7.00
Optical Cable Corp. engages in the business of manufacturing fiber optic and copper data communication cabling and connectivity solutions primarily for the enterprise market and various harsh environment, specialty markets, and the wireless carrier market offering integrated suites of high-quality products which operate as a system solution or seamlessly integrate with other components. Its products include fiber optic and copper cabling, hybrid cabling, fiber optic and copper connectors, specialty fiber optic, copper and hybrid connectors, fiber optic and copper patch cords, pre-terminated fiber optic and copper cable assemblies, racks, cabinets, datacom enclosures, patch panels, face plates, multimedia boxes, fiber optic reels, and other cable and connectivity management accessories. The company was founded on June 10, 1983 and is headquartered in Roanoke, VA.
KALV - KalVista Pharmaceuticals Inc - Stock Price Chart
TickerKALV [NASD, RUT]
CompanyKalVista Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap725.33MEPS (ttm)-3.75
P/E-EPS this Y12.71%
Forward P/E-EPS next Y36.73%
PEG-EPS past 5Y-17.63%
P/S-EPS next 5Y54.83%
P/B7.57EPS Q/Q-2.46%
Dividend-Sales Q/Q-
Insider Own22.58%Inst Own88.43%
Insider Trans2.18%Inst Trans-0.70%
Short Float21.97%EarningsJul 10/b
Analyst Recom1.00Target Price30.89
Avg Volume1.01M52W Range7.30 - 16.32
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Palleiko Benjamin LCHIEF EXECUTIVE OFFICERJul 09 '25Sale15.6932,979517,523369,595Jul 10 08:56 PM
Yea ChristopherCHIEF DEVELOPMENT OFFICERJul 09 '25Sale15.6930,250474,698127,939Jul 10 08:50 PM
Palleiko Benjamin LCHIEF EXECUTIVE OFFICERJun 09 '25Sale14.507,169103,950315,074Jun 10 05:00 PM
Audhya Paul K.CHIEF MEDICAL OFFICERMay 23 '25Sale11.312,14624,272113,026May 27 04:06 PM
Yea ChristopherCHIEF DEVELOPMENT OFFICERMay 23 '25Sale11.311,92621,78298,189May 27 04:05 PM
SKIN - Beauty Health Company - Stock Price Chart
TickerSKIN [NASD, RUT]
CompanyBeauty Health Company
CountryUSA
IndustryHousehold & Personal Products
Market Cap240.68MEPS (ttm)-0.41
P/E-EPS this Y-0.54%
Forward P/E-EPS next Y34.59%
PEG-EPS past 5Y-48.09%
P/S0.75EPS next 5Y-0.00%
P/B5.19EPS Q/Q15.23%
Dividend-Sales Q/Q-14.52%
Insider Own41.78%Inst Own56.54%
Insider Trans0.00%Inst Trans-2.82%
Short Float15.84%EarningsMay 08/a
Analyst Recom3.50Target Price1.66
Avg Volume929.87K52W Range0.78 - 2.38
The Beauty Health Co. engages in the design, development, manufacture, marketing, and sale of esthetic technologies and products. Its brands include Hydrafacial, SkinStylus, and Keravive. The company was founded in 1997 and is headquartered in Long Beach, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Paul BokotaGeneral CounselJun 06 '25Proposed Sale1.6012,00019,200Jul 01 04:05 PM
Gruber DesireeDirectorNov 20 '24Sale1.5014,66322,022119,514Nov 21 04:48 PM
SAUNDERS BRENT LChairmanAug 12 '24Buy1.0840,45043,6865,921,769Aug 13 05:00 PM
110151617181920